VENKATESAN JAY (See Remarks) reported 1 transaction at ELICIO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/29/2024ACC: 0001601485-24-000105
DirectorOfficer· See Remarks
Since Feb 2021
0.00
Net shares
Net seller
$500.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
50K acquired · 50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$0.01
Trade value
$500.00
% of position
38.6%
11/26/2024
129.58K→179.58K
Total
Net shares
+50K
Net value
$500.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2024 | X · X | +50K | $0.01 | $500.00 | 38.6% | 129.58K | 179.58K |
| Total | +50K | $500.00 | ||||||
Derivative Transactions1
Warrant to Purchase Common Stock
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
0.01
Held after
0.00
Exercisable
—
11/26/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common Stock Direct | Common Stock50K shares | 11/26/2024 | X · X | −50K | 0.01 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned953.00
Total
953.00 indirect953.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 953.00 | Indirect |
| Total | 953.00 | 953.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported